ReleaseWire Connect

The report discusses some of the reasons for the growth of carbon markets and provides carbon market forecasts until 2020.

Life Science Analytics’, Onychomycosis Therapy Area Pipeline Report contains detailed information on the onychomycosis drug pipeline. This report provides insight into the pipeline status of onychomycosis drugs by company and by stage as well as a summary of the latest news and developments in this area.

GlobalData's report, “HIV/AIDS – Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global HIV/AIDS market. The report identifies the key trends shaping and driving the global HIV/AIDS market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global HIV/AIDS sector. GlobalData estimated the HIV/AIDS market was worth $12 billion in 2009. The global Human Immunodeficiency Virus (HIV) infection market will continue to grow between 2009 and 2016 at a slower rate due to a series of patent expiries during this period. The growth rate is likely to decline from 2012 onwards due to the impact of the patent expiry of key drugs. The market is characterized by a high unmet need of drugs which can cure the disease. Highly Active Antiretroviral Therapy (HAART) which requires patients to take different classes of drugs has however succeeded in achieving near zero levels of HIV in infected people. Increased uptake of HAART and increasing awareness (which leads to increased treatment seeking) will drive the market. The pipeline for HIV is strong and consists of more than 250 molecules currently in development for various disease segments.

Life Science Analytics’, Osteoarthritis Therapy Area Pipeline Report contains detailed information on the osteoarthritis drug pipeline. This report provides insight into the pipeline status of osteoarthritis drugs by company and by stage as well as a summary of the latest news and developments in this area.

Life Science Analytics’, Osteoporosis Therapy Area Pipeline Report contains detailed information on the osteoporosis drug pipeline. This report provides insight into the pipeline status of osteoporosis drugs by company and by stage as well as a summary of the latest news and developments in this area.

Life Science Analytics’, Ovarian Cancer Therapy Area Pipeline Report contains detailed information on the ovarian cancer drug pipeline. This report provides insight into the pipeline status of ovarian cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.

Bank card is a modern financial instrument and the carrier of multiple financial businesses. Since Chinese first bank card was issued by Bank of China Zhuhai Branch in 1985, the functions of bank card are perfected progressively.

This monthly tracker covers product innovation, customer targeting, M&A, partnerships, organic growth, and staffing activity globally in the wealth management space.

The report is an essential source of information and analysis on the German prostate cancer therapeutics market. The report provides comprehensive information on prostate cancer, highlighting the treatment guidelines. It identifies and analyzes the key trends shaping and driving the German prostate cancer therapeutics market, and analyzes the treatment usage patterns.

Life Science Analytics’, Female Sexual Dysfunction Therapy Area Pipeline Report contains detailed information on the female sexual dysfunction drug pipeline. This report provides insight into the pipeline status of female sexual dysfunction drugs by company and by stage as well as a summary of the latest news and developments in this area.